Mélissa V. Wills

Dr. Mélissa V. Wills


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2025 in Surgical Endoscopy
Verified
Journal Article
Open access
MWMélissa V. Wills
Mélissa V. Wills
JBJuan S. Barajas-Gamboa
Juan S. Barajas-Gamboa
VMValentin Mocanu
Valentin Mocanu
ACAndrew Conner
Andrew Conner
JBJohn Brown
John Brown
MKMatthew Kroh
Matthew Kroh
Introduction: Superior mesenteric artery syndrome (SMAS) is caused by partial obstruction of the duodenum between the SMA and the aorta. While laparoscopic duodenojejunostomy (DJ) shows favorable short- and intermediate-term outcomes, characterization of long-term outcomes remains limited. Methods and procedures: An IRB-approved retrospective study was conducted on patients who underwent laparoscopic DJ from January 2007 to January 2023 at our center. SMAS diagnosis was confirmed through clinical presentation and radiographic studies. Data on BMI, symptoms, and nutritional support were collected preoperatively and at last follow-up. A McNemar test was performed to compare preoperative and long-term outcomes. Results: Twenty-five patients (median age 32.1 years, IQR 23.2–45.3) with a median follow-up of 5.3 years (IQR 3.0–8.5) were identified. BMI increased from median of 19.2 kg/m2 (IQR 17.8–21.1) to 21.6 kg/m2 (IQR 18.0–23.8) at the time of last follow-up (p = 0.005). The number of patients dependent on enteral tube feeds and total parenteral nutrition decreased within this time frame (36.0% to 28.0%, p = 0.4795). Fewer patients underwent procedures for enteral access placement preoperatively than by the time of last follow-up (36.0% to 12.0%, p = 0.1573). Abdominal pain (p < 0.001), nausea (p < 0.001), vomiting (p = 0.3657), bloating (p = 0.2568), and weight loss (p < 0.001) decreased within this time frame. No significant changes were observed in antiemetic (p = 0.7389) or prokinetic (p = 0.5637) use. Seven patients (28.0%) required major surgical interventions for diagnoses of gastrointestinal motility disorders. Four of these patients (16.0%) died during the final follow-up period. Conclusion: Laparoscopic DJ shows long-term benefits for SMAS, including improved BMI, reduced supplemental feeding dependence, and significant symptom relief, particularly for pain, nausea, and vomiting. However, a significant proportion of patients with concurrent gastrointestinal motility disorders had worse outcomes, required additional surgical interventions, and experienced higher mortality rates, underscoring the importance of both thorough preoperative evaluation and vigilant longitudinal follow-up for this complex patient population.

4 October 2024 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
MWMélissa V. Wills
Mélissa V. Wills
MAMohammad Hesam Alavi
Mohammad Hesam Alavi
EAEssa M. Aleassa
Essa M. Aleassa
CTChao Tu
Chao Tu
RWRickesha Wilson
Rickesha Wilson
AAAli Aminian
Ali Aminian
Introduction: Obesity is a major risk factor for idiopathic intracranial hypertension (IIH). Effective therapeutics for preventing disease progression and alleviating symptoms are limited. This study aims to examine the effects of bariatric surgery on clinical outcomes of IIH. Methods: We retrospectively collected data from the medical record of 97 patients with obesity and an existing diagnosis of IIH who underwent primary bariatric surgery at the Cleveland Clinic health system in the USA between 2005 and 2023. Pre- and postoperative data on presence of symptoms and clinical markers of IIH (headaches, visual field defects, papilledema, visual symptoms), intracranial pressure, and usage of IIH medications were compared. Results: A total of 97 patients (98% female, median age 46.7 years, median BMI 48.3 kg/m2) with IIH who underwent bariatric surgery including Roux-en-Y gastric bypass (n = 66, 68%), sleeve gastrectomy (n = 27, 27.8%), and gastric banding (n = 4, 4.1%) were analyzed. In a median follow-up time of 3.0 years, the median total weight loss was 24% (interquartile range, 13–33%). There was a significant improvement in headache, papilledema, visual field deficits, and visual symptoms after bariatric surgery. The mean lumbar opening pressure before and after bariatric surgery was 34.8 ± 8.2 cm CSF and 24.2 ± 7.6 cm CSF, respectively, with a mean reduction of 10.7 cm CSF (95% confidence interval, 4.7 to 16.6), p = 0.003. The dosage of acetazolamide and topiramate, as well as the number of medications taken for IIH, decreased significantly after bariatric surgery (p < 0.001). Conclusion: For patients who have obesity, bariatric surgery is a viable treatment modality for alleviation or improvement of symptoms of IIH.

Verified
Journal Article
Open access
PDF file
DEDoua Elamin
Doua Elamin
MWMélissa V. Wills
Mélissa V. Wills
JAJuan Aulestia
Juan Aulestia
VMValentin Mocanu
Valentin Mocanu
ASAndrew T Strong
Andrew T Strong
SNSalvador Navarrete
Salvador Navarrete
Background: Despite being one of the most performed bariatric procedures, there is no consensus regarding optimal limb lengths for Roux-en-Y gastric bypass (RYGB), which may impact weight loss and obesity-related comorbidity resolution. We hypothesize that a ratio-adjusted small bowel to Roux and BP limb lengths in RYGB results in superior outcomes. Objectives: This study aims to define total intestinal length (TIL) and the feasibility of its intraoperative measurement during RYGB. The findings will serve as a foundation for a subsequent randomized trial evaluating different limb length ratios and their effect on postoperative outcomes. Setting: This was a single-center prospective cohort study conducted at Cleveland Clinic Foundation-Main Campus, a tertiary referral center in the United States. Methods: Between January and June 2023, 25 patients with BMI > 40 undergoing RYGB were enrolled. Total small bowel length was measured intraoperatively, and feasibility of measurement was assessed. Patient outcomes, including total weight loss, 30-day complications, and comorbidities at 1 year were captured. Results: Mean preoperative BMI was 47.6 ± 8.0 kg/m2. Mean total small bowel length was 592 ± 93.3 cm, with a mean biliopancreatic (BP) limb length of 109 ± 29 cm (18.86% ± 5.84 of total length) and Roux limb length of 103 ± 15 cm (17.71% ± 3.06 of total length). Measurement added an average of 11.5 min to operative time. Measurement feasibility was rated as “moderate” or easier in 80% of cases. One-year postoperative outcomes included a mean total weight loss of 31% and significant reductions in antihypertensive and anti-diabetic medication use. Conclusions: Total small bowel length measurement during RYGB is safe and feasible. High variability in bowel length was observed, with no significant correlation to demographic factors. Establishing individualized limb length ratios may improve weight loss outcomes and comorbidity resolution. Further studies are warranted to evaluate the impact of tailored limb length strategies.

17 March 2026 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Open access
MWMélissa V. Wills
Mélissa V. Wills
SLSol Lee
Sol Lee
VMValentin Mocanu
Valentin Mocanu
YLYung Lee
Yung Lee
PKPattharasai Kachornvitaya
Pattharasai Kachornvitaya
RCRicard Corcelles
Ricard Corcelles
Weight recurrence and suboptimal response after metabolic and bariatric surgery (MBS) lack standardized definitions and management approaches, creating barriers to evidence-based treatment decisions and coordinated care across multiple specialties. To establish international expert consensus on terminology, diagnostic approaches, and management strategies for suboptimal response and weight recurrence after MBS. International Delphi study across multiple countries and health care systems. A two-round modified Delphi study was conducted with 66 international experts across five specialties (MBS, obesity medicine, gastroenterology, endocrinology, dietetics and nutrition, and psychology). A 164-item questionnaire was developed, spanning seven dimensions: conservative management, diagnostic methods, endoscopic interventions, quantitative thresholds, risk factors, surgical interventions, and terminology. Consensus was defined a priori as ≥70% agreement. Inter-rater reliability was assessed using Gwet's AC1 coefficient. Response rates were 54.5% (Round 1) and 57.6% (Round 2). Consensus achievement improved significantly between rounds (26.2% to 40.9% of items). Experts reached unanimous agreement on core management principles including individualized patient care (100%) and the appropriateness of specialists prescribing antiobesity medications (100%). Strong consensus emerged on standardized terminology with "suboptimal" as the preferred term (89.5%) and %TWL as the optimal measurement approach (94.6). For quantitative thresholds, consensus was achieved on surgical nonresponse defined as 25% of lost weight from nadir (70.3%), and a 10% change in %EWL from nadir as normal physiologic response (83.8%). Conservative management items achieved the highest consensus rates (80.9%) while quantitative threshold items require additional research (28.1%). Inter-rater reliability improved across all domains, with conservative management achieving substantial agreement (AC1 = .70). Expert consensus was achieved on fundamental principles of postbariatric care, including preferred terminology, measurement metrics, and provider roles. These recommendations address important gaps in clinical practice standardization.

20 March 2026 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
VMValentin Mocanu
Valentin Mocanu
MWMélissa V. Wills
Mélissa V. Wills
SNSalvador Navarrete
Salvador Navarrete
PKPattharasai Kachornvitaya
Pattharasai Kachornvitaya
XZXinlei Zhu
Xinlei Zhu
Jerry DangJerry Dang
Jerry Dang

25 September 2025 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
JBJuan Sebastian Barajas-Gamboa
Juan Sebastian Barajas-Gamboa
KKKayanne Khoury
Kayanne Khoury
VMValentin Mocanu
Valentin Mocanu
MWMélissa V. Wills
Mélissa V. Wills
TSThomas H Shin
Thomas H Shin
Jerry DangJerry Dang
Jerry Dang
Introduction: Concomitant liver biopsy during bariatric surgery has gained interest for diagnostic and research purposes, particularly in studying obesity-related liver disease. However, comprehensive data on safety remains limited using recent national databases. Methods: A retrospective analysis of the MBSAQIP database from 2020 to 2022 was conducted. Patients undergoing primary Roux-en-Y gastric bypass or sleeve gastrectomy with or without concomitant liver biopsy were included. Primary outcomes were 30-day major complications (Clavien-Dindo grade III and IV) and mortality. Separate multivariable analyses were performed for bleeding-related complications including postoperative bleeding, transfusion requirements, and reoperation. Multivariable logistic regression analysis determined if concomitant liver biopsy independently predicted adverse outcomes. Results: Of 511,981 patients, 30,819 (6.02%) underwent concomitant liver biopsy. Biopsy patients had higher rates of diabetes (28.25% vs 22.65%, p < 0.001) and hyperlipidemia (25.20% vs 22.14%, p < 0.001). Mean operative time was longer in the biopsy group (96.10 vs 83.59 min, p < 0.001). Unadjusted analysis showed higher rates of major complications (Clavien-Dindo grade III and IV) (3.15% vs 2.70%, p < 0.001) and 30-day readmission (3.32% vs 2.86%, p < 0.001) in the biopsy group. However, on multivariable analysis, concomitant liver biopsy was not independently predictive of major complications (OR 0.91, 95%CI 0.79–1.04, p = 0.164) or 30-day readmission (OR 1.06, 95%CI 0.94–1.21, p = 0.344). Separate multivariable analyses for bleeding-related complications revealed that concomitant liver biopsy was independently associated with increased postoperative bleeding (OR 1.203, 95%CI 1.018–1.422, p = 0.030) and transfusion requirements (OR 1.171, 95%CI 1.028–1.334, p = 0.018), but not with reoperation (OR 1.016, 95%CI 0.908–1.138, p = 0.783). Conclusion: After adjusting for patient factors, concomitant liver biopsy during bariatric surgery does not independently increase the risk of major complications (Clavien-Dindo grade III and IV), readmission, or mortality. However, it is associated with increased bleeding and transfusion complications. These findings support that liver biopsy can be performed during bariatric surgery, though clinicians should be prepared for increased bleeding-related risks and blood product utilization.